Watch Now: Webinar – Overcoming Regulatory Challenges for Cell & Gene Therapy Products

Overcoming Regulatory Challenges for Cell & Gene Therapy Products

Bringing an Advanced Therapy Medicinal Product (ATMP) to market is a complex process, requiring a deep understanding of regulatory requirements, scientific rigor, and compliance excellence. With increasing scrutiny from regulatory authorities such as the FDA and EMA, pharmaceutical companies must proactively address compliance challenges for cell-based therapies, gene therapies, and combined ATMPs.

In this exclusive on-demand webinar, our experts explore strategic approaches to overcoming ATMP regulatory hurdles, ensuring compliance, and streamlining approvals in global markets.

Don’t miss this opportunity to enhance your regulatory skills and understanding.

Explore More on ATMP Regulatory Challenges

📖 ATMP Regulation in the EU and US: Global Convergence? – Learn about the regulatory alignment efforts between the FDA & EMA and what this means for ATMP manufacturers.

📖 Navigating the Complex CMC Landscape of ATMPs and CGTs – Understand the key challenges and strategies for Chemistry, Manufacturing, and Controls (CMC) in ATMP and CGT development.